Neurocrine Biosciences Stock Price (NASDAQ:NBIX)

Add to My Stocks
$51.1 $0.41 (0.8%) NBIX stock closing price Apr 21, 2017 (Closing)
Neurocrine Biosciences
21 APR 2017
amigobulls logo
NBIX hand_up
NBIX vs S&P 500
Closing Price: Apr 21, 2017
$51.1 ( -0.8%)
S&P 500
2348.7 ( -0.3%)
52 Week Price Range
1 Year Return: 4.72%
Q4 Growth*
Profitable ?
net image
2016 Q4 Net Loss
Pays Dividend ?
12 Months Dividend
  : $0
Dividend Yield
  : -99900%
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Neurocrine Biosciences Snapshot Video

14 5 2

NBIX Stock Details

Prev Close* : $51.51
Market Cap:
Day Low: $50.67
52 Week Low: $37.35
Open: $51.3
Volume: 882465
Day High: $52.12
52 Week High: $55.15

Neurocrine Biosciences Stock Articles & Video

more news on NBIX stock

Neurocrine Biosciences News - From Partners

Company News for April 13, 2017   by Zacks on Apr 13, 2017

NBIX Stockcharts

View NBIX PE ratio, PS ratio stocks charts and compare with peers.
NBIX Chart
Note: Compare Neurocrine Biosciences stock price history with the index and industry peers.

Neurocrine Biosciences Financial Ratios

Receivables Turnover

NBIX Industry Peers

Company Price Change (%)
Taro Pharma (TARO)115.571.04 (0.89%)
Ariad Pharma (ARIA)23.990 (0%)
Abbvie (ABBV)63.820.04 (0.06%)
Repros Therapeutics (RPRX)0.990.02 (1.98%)
Auspex Pharma (ASPX)100.960 (0%)
Sage Therapeutics (SAGE)72.821.19 (1.66%)
Pfizer (PFE)33.640.1 (0.3%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Aratana Therapeutics (PETX)6.160.29 (4.94%)
Redhill Biopharma (RDHL)10.380.41 (4.11%)
Ionis Pharma (IONS)44.261.35 (3.15%)
Spectrum Pharma (SPPI)7.090.12 (1.72%)
PTC Therapeutics (PTCT)11.370.12 (1.07%)
Nutraceutical International (NUTR)29.90.2 (0.67%)
Arrowhead Pharma (ARWR)1.520.01 (0.66%)
Top gainers from Medical-Drugs industry
* As of Apr 22, 2017
CompanyPriceChange (%)
Corcept Therapeutics (CORT)9.110.88 (8.81%)
AcelRx Pharma (ACRX)2.550.15 (5.56%)
Rigel Pharma (RIGL)2.870.16 (5.28%)
Cumberland Pharma (CPIX)5.940.31 (4.96%)
Galectin Therapeutics (GALT)3.090.14 (4.33%)
Aralez Pharma (ARLZ)1.570.07 (4.27%)
Valeant Pharmaceuticals Intl Inc (VRX)8.510.37 (4.17%)
Top losers from Medical-Drugs industry
* As of Apr 22, 2017

Neurocrine Biosciences, Inc. Stock News - Partner Headlines

Neurocrine Biosciences Financial Statements

income statement20162015201420132012
Net Sales Or Revenues15M19.76M-2.91M53.14M
Net Income-141.09M-88.92M-60.54M-46.09M5.02M
Total Operating Expense162.37M113.97M64.4M52.58M51.68M
view Neurocrine Biosciences, Inc. income statement
balance sheet20162015201420132012
Total Assets365.08M474.78M243.03M154.67M195.97M
Total Liabilities50.2M50.33M34.33M34.26M41.6M
Shareholders Equity314.87M424.45M208.69M120.41M154.37M
view Neurocrine Biosciences, Inc. balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities5.78M8.7M1.6M12.23M-13.36M
Net Cash From (Used By) Operating Activities-106.18M-37.99M-47.14M-29.6M-35.29M
Increase (Decrease) In Prop Plant And Equipment-4.09M-1.92M-1.56M-0.5M-0.93M
view Neurocrine Biosciences, Inc. cashflow statement

Neurocrine Biosciences Stock Message Board

Neurocrine Biosciences stock lost -0.8 %, and the last close price as of 21 Apr, 2017 is 51.1 for NBIX stock. Looking at Neurocrine Biosciences market capitalization, which currently stands at 4.49B, we can say that NBIX stock is a Mid cap stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Neurocrine Biosciences stock analysis.

Demand for a stock decides its stock market price. For example, if more investors want to buy NBIX stock than sell it, then Neurocrine Biosciences stock price goes up. Conversely, if more investors wanted to sell NBIX stock than buy it, there would be greater supply than demand, and the stock price would fall. 882465 NBIX shares were traded yesterday, and Neurocrine Biosciences stock chart shows that the NBIX stock quote hit a day high of 52.12 and day low of 50.67. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. One can observe stock price trends and check for volatility by checking Neurocrine Biosciences stock price history.